FibroBiologics

FBLGNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.359 M

$0.94 -4.12%

Close of 6 Nov 2026

As of 6 Nov 2026, FibroBiologics (FBLG) has a market capitalization of $6.36M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$18.6M

Loss-making

Shares outstanding

6,658,193

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#438Ensysce BiosciencesENSC$6.65M
#439Kiora PharmaceuticalsKPRX$6.64M
#440FibroBiologicsFBLG$6.36M
#441Enveric BiosciencesENVB$6.36M
#442CNS PharmaceuticalsCNSP$6.01M

What if FibroBiologics were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,162,770

Per share 4,440,762× higher

Bitcoin $1.53T

$225,240.25

Per share 240,282× higher

Apple $5.02T

$739,442.72

Per share 788,823× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for FibroBiologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.